Discover insights into manufacturing and the Pharmacy 500 companies that shape the industry in the Pharmacy500 Platinum Pages 2026 publication!
A branded pharmaceutical manufacturer is a company that develops, produces, and markets pharmaceutical products under a proprietary brand name. These companies are responsible for the research, development, and commercialization of new drugs, which are often protected by patents and exclusive marketing rights for a certain period. Branded pharmaceutical manufacturers are also involved in extensive regulatory approval processes, clinical trials, and post-market surveillance to ensure the safety and efficacy of their drugs. These manufacturers play a critical role in providing innovative treatments for a wide range of medical conditions but also face challenges such as patent expiration, competition from generics, and the high costs of R&D.
A generic drug manufacturer is a company or entity that produces generic versions of branded pharmaceutical products once the original drug’s patent protection expires. These manufacturers are responsible for developing, producing, and marketing generic drugs that are bioequivalent to the original branded drugs. They ensure that the generic product contains the same active ingredient(s), is administered in the same dosage form, and delivers the same therapeutic effect as the branded version, while adhering to regulatory standards set by agencies such as the U.S. Food and Drug Administration (FDA) or other relevant national regulatory bodies. These manufacturers play a critical role in expanding access to essential medications while promoting competition in the pharmaceutical industry.
YARAL Pharma Inc., launched in 2022, is the U.S. generics subsidiary of IBSA (Institut Biochimique SA), a multinational pharmaceutical company headquartered in Lugano, Switzerland. Built on IBSA’s commitment to “drugs in the best form,” YARAL delivers high-quality, affordable, authorized and complex generic medicines across key therapeutic areas—including endocrinology and pain and inflammation—while ensuring continuity of supply and patient-focused innovation.
Created to expand IBSA’s presence in the U.S. market, YARAL combines global manufacturing excellence with a customer-first approach. Since its launch, the company has quickly become one of IBSA’s top-performing subsidiaries, recognized for its consistent product quality, reliability of supply, and responsive service.
YARAL’s portfolio focuses on high-value, differentiated generics—including topical and transdermal patches and softgel technologies—that meet real needs in today’s pharmacy practice. Guided by quality, reliability, and innovation, YARAL is helping pharmacists provide patients with trusted treatment options across multiple therapeutic areas.
The Pharmacy500 is awarded to 500 pharmacy supply chain businesses and associations that significantly impacted dispensing pharmacies in the U.S. over the past year.
The following are complimentary benefits extended to Pharmacy500 companies and associations (coming this spring!)
Discover insights into manufacturing and the Pharmacy 500 companies that shape the industry in the Pharmacy500 Platinum Pages 2026 publication!
The 2026 Pharmacy500 Companies Market Teardown report provides a concise snapshot of the 2026 companies, highlighting new additions, examining regional distributions, practice settings, supply chain categories, and key conferences attended.
RXinsider’s Pharmacy500 Careers Outlook report identifies key employment trends and workforce dynamics across Pharmacy500 companies. Check out this report to learn more about open position trends and the current state of the job market impacting the pharmacy supply chain!
Fortune Magazine’s annual Fortune 500 ranks the largest U.S. companies by revenue. Many leaders in healthcare and pharmaceuticals drive medication production, distribution, and patient access. This report highlights their impact on the pharmacy industry.
YARAL Pharma delivers high-quality, authorized, and complex generics across multiple therapeutic areas, with reliable supply and exceptional service. Learn more by exploring our 20Ways publications!
TYZAVAN™ by Hikma Pharmaceuticals is the only FDA-approved, ready-to-use, shelf-stable, room-temperature-stable vancomycin premix injection available in seven strengths. Learn more in this issue of 20Ways!
With offerings of more than 13,500 products needed for your pharmacy, spanning from branded and generic drugs, OTC medications, pharmacy operations supplies, and MORE. Learn more by exploring our 20Ways Publications.
RXinsider’s Pharmacy500 Academy now offers training on generics, brand name & biotech drug manufacturing, along with product comparisons and company breakdowns. Visit the Pharmacy500 Academy to learn more about drug manufacturing.
AIS Healthcare
Amneal Pharmaceuticals LLC
Azurity Pharmaceuticals, Inc.
B. Braun Medical Inc.
Baxter
Central Admixture Pharmacy Services, Inc. (CAPS)
Cipla, Inc.
Civica
Dr. Reddy’s Laboratories Ltd.
Empower Pharmacy
Esco
Fagron
Fresenius Kabi Group
Germfree
Grifols
Hikma Pharmaceuticals
IsoTech Pharma
Leiters Health
LGM Pharma
McKesson Corporation
Medivant Healthcare
Moderna, Inc.
Nephron Pharmaceuticals Corporation
McKesson Corporation
OurPharma LLC
Par Health
Pine Pharmaceuticals
Precision Dose, Inc.
Quva
Revelation Pharma
SCA Pharma
STAQ Pharma, Inc.
Turbare Manufacturing
Wells Pharma
West Pharmaceutical Services, Inc.
YARAL Pharma Inc.
